(CSX) has a trading volume of 5.29 Million shares, with an average trading volume of 5210 shares - with shares dropping to a 52 week low of $23.97, and the company's shares hitting a 52 week high of $ 50.31. The company's stock has climbed 1.75 percent in the past five year. The stock remained 1.92% volatile for the week and 1.92% for the month. Spirit of America Management Corp NY raised its position in shares of CSX by 35.0% in the third quarter. Ballentine Partners LLC now owns 8,250 shares of the company's stock worth $252,000 after buying an additional 138 shares during the last quarter.
NA cut its stake in shares of CSX Co.
The company's stock rose $1.33, or almost 3 percent, to $48.26 in after-hours trading following the release of the earnings report. Charter Trust Co. raised its position in CSX by 6.4% in the third quarter. GHP Investment Advisors Inc. now owns 71,989 shares of the company's stock valued at $2,196,000 after buying an additional 1,981 shares during the period. Municipal Employees Retirement System of MI now owns 30,270 shares of the company's stock worth $923,000 after buying an additional 90 shares during the last quarter. Finally, Russell Investments Group Ltd. purchased a new stake in shares of CSX during the fourth quarter valued at about $15,156,000. That suggests something of the likelihood of a short squeeze in shares of CSX.
On Thursday, Cara Therapeutics Inc (NASDAQ:CARA) stock opened its trade at $18.12 and after floating in a range of $17.52 to $18.29, settled at $17.53. Stock traders acquired 9,302 put options on the stock. The firm has a 50-day moving average price of $47.41 and a 200 day moving average price of $40.23.
NewsAlert: Flames eliminated from Stanley Cup playoffs after loss to Ducks
Allen was caught behind the net as he played the puck, and it went directly to Coyle, who scored his second goal of the series. Bouma and Stajan have zero points combined in the Flames' first three games of the series.
CARA stock's price is now -16.12% down from its 52-week high and +302.99% up from its 52-week low.
CSX (NASDAQ:CSX) last issued its quarterly earnings results on Tuesday, January 17th. The Manufacturers Life Insurance Company bought a new stake in shares of CSX during the third quarter worth approximately $27,459,000. Analysts expected $2.76 billion. CSX had a net margin of 15.48% and a return on equity of 14.71%. CSX's revenue for the quarter was up 2.8% compared to the same quarter previous year. During the same period in the prior year, the firm posted $0.48 EPS. On average, equities research analysts predict that CSX Co. will post $2.07 EPS for the current fiscal year.
CSX has been the subject of several recent research reports. Zacks Investment Research downgraded CSX from a "buy" rating to a "hold" rating in a report on Monday, February 6th. Morgan Stanley upgraded CSX from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $24.00 to $37.00 in a research note on Thursday, January 19th. The stock tapped a 52-week high of US$136.5 while the mean 12-month price target for the shares is US$138.76. Atlantic Securities upgraded CSX from a "neutral" rating to an "overweight" rating and set a $57.00 price objective for the company in a report on Wednesday, March 15th. (CSX) where 10 analyst have rated the stock as Strong Buy, 8 analysts said it's a Buy, 10 rated the stock as Hold, 1 analysts reported Underperform and 0 analysts gave their recommendations as Sell. CSX now has a consensus rating of "Buy" and a consensus price target of $54.88. For CSX, the company now has $603 Million of cash on the books, which is offset by $331 Million current liabilities.
Comments